Trials

TUSTIN, CA: Investigational New Drug Application Filed With the FDA to Advance Lead Imaging Candidate 124I-PGN650 Into Clinical Development; AACR Presentation Shows Increased Exposure of Phosphatidylserine (PS) F ...

Biolog Announces Appointment of Distributors in Europe

HAYWARD, CA: ...

Threshold Pharmaceuticals Announces Multiple Data Presentations on TH-302 at the 2012 AACR Annual Meeting

SOUTH SAN FRANCISCO, CA: Oral, Late-Breaking Presentation and Subsequent Webcast to Detail Efficacy and Safety Data From Phase 2b Trial of TH-302 in Pancreatic Cancer ...

Peregrine Pharmaceuticals Announces Receipt of Notice From NASDAQ

TUSTIN, CA: ...

WorldCare Clinical, in Conjunction With the Massachusetts General Hospital (MGH) Department of Radiology, Announces the Imaging Biomarkers in Clinical Trials Conference

BOSTON, MA: ...

bioRASI to Exhibit at the 2012 GPhA Annual Meeting in Orlando, FL

AVENTURA, FL: The Leading ANDA and 505(b)(2) CRO to Showcase Ophthalmic Clinical Program Optimization Techniques ...

WorldCare Clinical Expands Capabilities With Introduction of New Service Offering for Cardiovascular Endpoint Committees

BOSTON, MA: ...

Peregrine to Present at BIO CEO and Investor Conference on Tuesday, February 14, 2012 at 8:30 AM EST

TUSTIN, CA: ...

Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis

PLANEGG, GERMANY and MUNICH, GERMANY: ...

Sernova to Present Company and Clinical Update at Biotech Showcase(TM) San Francisco

LONDON, ONTARIO: ...

Bioanalytical Systems to Present at the Sidoti & Company Semiannual Micro-Cap Conference, Monday, January 9, at 4:00 p.m. EST

WEST LAFAYETTE, IN: ...

Page 8 von 9: 1 2 3 4 5 6 7 8 9

All members:	10 667
Register today:	0
Register yesterday:	0
Members online:	0
Guests online:	300

Trials

Category / Pharmaceuticals & Biotech / Trials

Cromos(TM) Pharma Announces Participation in ASCO 2012 on June 1-5 in Chicago, IL

RayBiotech, Inc. Establishes Master Services Agreement With Major Biopharmaceutical Company

Agile Therapeutics President and Chief Executive Officer Al Altomari Is an Ernst & Young Entrepreneur Of The Year(R) 2012 Finalist in New Jersey

SciClone Reports Financial Results for the First Quarter 2012

Agennix AG Reports Financial Results for First Quarter of 2012

Agennix AG Schedules Conference Call on May 9 to Discuss First Quarter 2012 Financial Results

Researchers at DSMZ Develop Innovative Software for Biolog Phenotypic Analyses to Improve Our Understanding of the Metabolic Processes of Microorganisms and Other Cells

Cytokinetics to Announce First Quarter Results on April 26, 2012

Cytokinetics Announces CK-2017357 Receives Fast Track Designation From the FDA for the Potential Treatment of Amyotrophic Lateral Sclerosis

Peregrine Launches PS-Targeting Clinical Imaging Program